Introduction to the information for preventing and managing cardiovascular diseases, such as ischemic heart disease, hypertension, and heart failure. 介绍有关心血管病防治方面的信息， 诸如缺血性心脏病，高血压和心衰。
Learn more （点击）》
Introduction to the information for preventing and managing psychological and/or developmental disorders, such as autism, depression, and obsessive compulsive disorder. 介绍有关防治心理和/或发育障碍方面的信息, ...
Learn more （点击）》
Introduction to the information for health and general well being, including exercise, diet and nutrition. 介绍有关健康的信息，包括锻炼身体，饮食和营养。
Learn more （点击）》
Introduction to the information for preventing and managing cardiovascular diseases, such as ischemic heart disease, hypertension, and heart failure.
Learn more »Introduction to the information for preventing and managing psychological and/or developmental disorders, such as autism, depression, and obsessive compulsive disorder.
Learn more »Introduction to the information for health and general well-being, including exercise, diet and nutrition. 介绍有关健康的信息，包括锻炼身体，饮食和营养。
Learn more »A meta-analysis of randomized controlled trials concluded that colchicine treatment may reduce the risk of cardiovascular events in patients with coronary artery disease (CAD). The analysis included 5 randomized controlled trials with follow-up duration ≥6 months, comprising a total of 11,790 patients with CAD. Compared with placebo or no treatment, […]
The 2020-2025 Dietary Guidelines for Americans are out. For the first time the Guidelines provide recommendations by life stage, from birth through older adulthood, while focusing on dietary patterns and recognizing that more than half of adults have one or more diet-related chronic diseases. The guidelines: for about the first […]
A US cohort study suggested that in the absence of evidence of end-organ damage, conservative management of inpatient high blood pressure (BP) was associated with improved outcomes compared with more intensive management. The study included 22 834 adults hospitalized for noncardiovascular diagnoses from January 1 to December 31, 2017 (mean age, […]
A harmonized meta-analysis concluded that longer sedentary time is associated with higher mortality in less active individuals when measured by accelerometry. About 30–40min of moderate-to-vigorous-intensity physical activity (MVPA) per day attenuate the association between sedentary time and risk of death. The analysis included 44370 middle-aged and older men and women […]
Ten metabolites from seven prospective cohort studies were found to be associated with risk of stroke. The studies included 1,791 incident stroke events among 38,797 participants. Independent of traditional risk factors including hypertension, diabetes, smoking, and body mass index, amino acid histidine (hazard ratio [HR] per standard deviation [SD] = […]
Two studies suggest that low-density lipoprotein cholesterol (LDL-C) may not to be the main lipid contributor to atherosclerotic cardiovascular disease (ASCVD). The study in Spain included 6901 subjects in the high-risk primary prevention trial population (mean age: 67 years; body mass index: 30 kg/m2; 43% men; 48% with diabetes) with […]
A US randomized clinical trial revealed that a low-fat plant-based diet is effective in reducing body weight and increasing insulin sensitivity and postprandial metabolism. A total of 244 participants with body mass index of 28 to 40 (87% female, 48% White, mean age 54.4 years) were randomized in a 1:1 […]
A US prospective cohort study suggests that most gout cases could potentially be prevented by achieving and maintaining a normal weight, eating a DASH-style diet, and avoiding alcohol consumption and diuretic use. Men with obesity may not benefit from other modifications unless weight loss is addressed. The study included 44 654 […]
The secondary analysis of a US randomized, double-blind, placebo-controlled clinical trial suggested that vitamin D3 apparently reduced the risk of developing advanced cancer among adults who have normal but not elevated body mass index (BMI). The trial included 25 871 randomized participants (51% female; mean age, 67.1 years), 1617 were diagnosed […]
A randomized, double-blind, placebo-controlled trial in chronic kidney disease (CKD) and type 2 diabetes (T2D) concluded that treatment with finerenone reduced risks of CKD progression and cardiovascular (CV) events. Between September 2015 and June 2018, 5734 patients with CKD and T2D were randomly assigned in a 1:1 ratio to receive […]
